ARTICLE | Finance
General trickle
Why one ETF manager thinks biotech has room to run
August 3, 2015 7:00 AM UTC
Although biotech indices have advanced at least 2% this quarter and are frequently touching new highs, Paul Yook of LifeSci Capital expects the sector has more room to run. The reason, he said, is generalist investors have not entered biotech en masse.
"Generalists are not involved in biotech in a huge way. Thus, I don't really believe we're near a top," Yook told BioCentury...